Laboratory Liquidation Services

Laboratory Liquidation Services for Biotech, Pharma & Research Facilities

pForm helps laboratories, biotech companies, pharmaceutical teams, universities, CROs, and research facilities recover value from surplus lab equipment during closures, relocations, consolidations, downsizing, and facility wind-downs. Our laboratory liquidation services span valuation, disposition strategy, buyer outreach, and removal coordination — built for time-sensitive situations.

Lab equipment valuation

Asset recovery strategy

Auction, resale, and consignment support

Closure timeline coordination

Compliance-aware documentation

Freight and pickup coordination

Lab closures move fast. The moment a facility is scheduled to wind down, the value of the equipment inside it starts to compete with every other priority — vacating leases, returning sites to landlords, decommissioning utilities, and meeting obligations to investors, partners, or creditors.

Without a structured liquidation plan, valuable instruments quietly disappear into dumpsters, get abandoned past the lease-end date, or sell well below market because the team running the closure was never set up to negotiate disposition channels. Liquidating lab assets effectively means protecting recoverable value, documenting disposition, coordinating qualified buyers, and aligning removal logistics with the actual closure deadline.

That's what pForm is built for. We treat lab equipment liquidation as an operational discipline — not a fire sale.

Overview

What are laboratory liquidation services?

Laboratory liquidation services bundle the operational steps required to convert surplus lab equipment into recovered cash, while keeping the closure timeline intact and the paper trail clean. The work spans:

  • Asset review.Inventory the equipment footprint, separate recoverable assets from scrap, identify high-value instruments.
  • Equipment valuation.Estimate realistic recovery by channel — direct sale, consignment, auction — based on current buyer demand.
  • Disposition strategy.Match each segment of the asset list to the right channel: auction, direct purchase, consignment, or bulk recovery.
  • Buyer outreach.Surface qualified buyers through targeted outbound and supporting marketplaces, including mLab Supply where appropriate.
  • Removal coordination.Schedule freight, pickup windows, palletizing, and site access against the closure deadline.
  • Documentation.Asset disposition records, buyer documentation, and closeout reporting for the client, counsel, or creditors.

Closure contexts

Lab closure services for time-sensitive facility changes

Most laboratory liquidations sit inside a larger facility event. The pressure on the team running it usually comes from a deadline — a lease, a board decision, a settlement date, or a closeout obligation — and the equipment recovery has to fit that timeline. We support lab closure services across the full range of contexts:

  • Biotech shutdowns and full corporate wind-downs
  • Pharmaceutical site consolidation and R&D footprint reduction
  • University and academic lab moves
  • CRO and CDMO downsizing
  • Startup wind-downs after pipeline failure or pivot
  • Lease-end cleanouts and facility handbacks
  • Facility relocations and inter-site transfers
  • Surplus inventory reduction and equipment refresh projects
  • Receivership and creditor-driven wind-downs

Equipment

Lab equipment liquidation categories we commonly handle

Most laboratory liquidations include a mix of analytical, bioprocessing, cold storage, and general equipment. Items may be sold individually, bundled, auctioned, consigned, or directly purchased depending on condition, urgency, demand, and recovery goals.

Analytical instruments

HPLC, GC, LC/MS, GC/MS, spectrophotometers, plate readers, UV-Vis, FTIR.

Bioprocessing

Bioreactors, fermenters, pumps, controllers, filtration skids, single-use systems.

Cold storage

ULT freezers, lab refrigerators, cryogenic equipment, controlled-rate freezers.

General lab equipment

Centrifuges, incubators, balances, microscopes, water purification, vacuum systems.

Automation

Liquid handlers, robotic systems, plate stackers, integrated workstations.

Pharma & manufacturing support

Inspection systems, packaging equipment, and cleanroom-adjacent equipment where applicable.

Process

Our process for liquidating lab assets

Every engagement runs through the same seven steps. The depth of each one scales with the size of the project — a single-room cleanout finishes in a day or two; a multi-site biotech wind-down is the same process at higher resolution.

  1. 01

    Initial consultation and timeline review

    We start with a short call to understand the closure context, deadline, and the scope of the equipment footprint.

  2. 02

    Asset list, photo, or site review

    Spreadsheet, manufacturer/model data, photos — or, for larger projects, an on-site walkthrough.

  3. 03

    Market valuation and recovery estimate

    Channel-specific recovery estimates based on current buyer demand and the condition of the asset mix.

  4. 04

    Disposition strategy

    Direct sale, consignment, auction, bulk purchase, or a hybrid — selected to balance recovery against your timeline.

  5. 05

    Buyer outreach and marketplace positioning

    Targeted outreach across our buyer network and supporting marketplaces, including mLab Supply where appropriate.

  6. 06

    Logistics, removal, pickup, and freight coordination

    Scheduling with the facility, buyers, and transit providers — aligned to your closure or handback date.

  7. 07

    Documentation and closeout reporting

    Disposition records, buyer documentation, and a final closeout report with the realized recovery breakdown.

Channel selection

Auction, direct purchase, consignment, or hybrid recovery strategy

There is no single best path. The right channel for liquidating lab assets depends on the mix of equipment, the urgency, and what the client is optimizing for — speed of close, total recovery, predictability, or operational simplicity.

MethodBest forAdvantagesTradeoffs
Direct purchaseFast, predictable closure with one transaction.Single payment, single removal window, minimal coordination.Bulk price; typically below auction-best on in-demand instruments.
ConsignmentQuality instruments where time allows for individual sale.Higher realized value than bulk on most analytical equipment.Recovery happens over weeks-to-months; storage logistics required.
Online auctionMixed inventory with several high-demand instruments.Buyer competition pushes price on in-demand assets.Variable outcomes; requires a defined auction window.
Managed liquidation programMulti-site or recurring surplus across an enterprise.Consistent process across sites; ongoing recovery reporting.Higher initial setup; designed for organizations with sustained surplus.
Hybrid recoverySingle-event closures with both premium and bulk equipment.High-value assets go to auction or consignment; remainder cleared via direct purchase.Requires sorting and dual coordination; pForm handles the orchestration.

Why pForm

Why pForm is different from a generic surplus buyer

Most surplus buyers offer one price for the whole lot and move on. That works when the goal is speed at any cost. When the goal is actually recovering value from biotech, pharma, or research equipment, the process needs to look different.

  • Not a one-price bulk buyer.We look at the asset list per category and route each segment to the channel that actually fits it.
  • Domain knowledge.Our team understands biotech and pharma equipment categories well enough to spot which instruments warrant individual treatment.
  • Multiple recovery paths.Direct acquisition, auction, consignment, and marketplace routing — including mLab Supply for appropriate assets — under one engagement.
  • Operational lift.We reduce the burden on internal teams during closures so leadership can focus on the closure itself.
  • Documentation discipline.Asset tracking, recovery planning, and closeout records that survive an audit or a creditor review.
  • Deadline-aware.We treat lease-end and facility deadlines as primary constraints, not as inconveniences.

We don't make exaggerated guarantees about "highest prices." Recovery depends on equipment, demand, and timeline — we explain those tradeoffs honestly up front.

What goes wrong

Risks during a lab closure or equipment liquidation

Most of the value lost during a lab closure isn't lost at the buyer's table — it's lost in the operational gap between the decision to close and the day removal actually happens. Common failure modes:

  • Equipment abandoned after lease end because removal wasn't scheduled in time.
  • Valuable instruments scrapped early when an internal team underestimates resale value.
  • Poor asset documentation that prevents accurate buyer valuation.
  • Untested equipment that loses recovery because no functional record exists.
  • Missed resale windows when timelines slip past peak buyer demand.
  • Uncoordinated removals that block other site activities.
  • Unclear buyer qualification that lets equipment leave without payment or paperwork.
  • Freight delays when transit hasn't been pre-scheduled.
  • Landlord or facility access constraints — limited dock or elevator hours, restricted parking.
  • Data-bearing devices or sensitive systems that require internal IT and EHS review before transfer.

Documentation

Compliance and documentation considerations

pForm can help organize asset information, disposition records, buyer documentation, and closeout reporting suitable for trustees, receivers, landlords, and internal audit.

Clients remain responsible for their own EHS, decontamination, hazardous material handling, regulated waste, and legal or regulatory decisions about specific equipment categories. pForm may coordinate with qualified vendors when needed, but does not act as a licensed appraiser, environmental services provider, certified decontamination contractor, or regulated waste handler.

For projects with significant compliance obligations, review our compliance & risk approach and bring the relevant counsel and EHS resources into the engagement early.

Before you reach out

What to prepare before requesting a lab liquidation review

You don't need a polished inventory to start. A rough list and your timeline is enough to scope the engagement and return a recovery estimate. The more of the items below you can include, the tighter the estimate.

  • Asset list or spreadsheet
  • Photos of major instruments
  • Manufacturer and model numbers
  • Serial numbers if available
  • Quantity per asset type
  • Condition and test status (working, untested, parts-only)
  • Location (building, room, floor)
  • Timeline or hard deadline
  • Loading dock, elevator, pallet jack, or forklift access details
  • Known decontamination or facility requirements
Submit Your Equipment List →

Service area

Where we operate

pForm is based in Southern California and supports laboratory liquidation and asset recovery projects for biotech, pharma, academic, and research organizations across California — including the San Diego biotech cluster — and the broader West Coast. We also support remote asset review and out-of-area projects through a structured intake, photo, and asset-list process.

For multi-site or enterprise programs, see our enterprise asset recovery programs and industries we work with.

FAQ

Laboratory liquidation services — frequently asked questions

What are laboratory liquidation services?+

Laboratory liquidation services are a structured way to recover value from surplus lab equipment during a closure, relocation, downsizing, or facility wind-down. A typical engagement includes asset review, equipment valuation, channel selection (direct sale, consignment, auction, or bulk purchase), buyer outreach, freight coordination, and closeout documentation.

How do I liquidate used lab equipment?+

Start by assembling an asset list with manufacturer, model, serial number when available, condition, and location. Send it to pForm with your timeline. We review the list, return a market valuation, recommend a disposition channel, and coordinate buyers and removal so your team can stay focused on the closure itself.

Do you buy surplus lab equipment directly?+

Yes — direct purchase is one of the options pForm offers when a fast, clean exit matters more than maximizing every dollar. We also run consignment and auction paths when the timeline allows for buyer competition. The right answer depends on the asset mix, condition, and your deadline.

Is an auction or a direct sale better for lab equipment?+

Neither is universally better. Direct sale and bulk purchase are fastest and most predictable. Auctions and managed marketplace listings typically yield higher recovery on in-demand instruments but take longer and depend on bidder participation. A hybrid program often beats either path alone — high-demand instruments to auction, the rest to bulk purchase.

How long does a lab liquidation take?+

A focused liquidation of a single lab can wrap in two to four weeks once the asset list is finalized. Larger multi-site programs, receivership work, and auction-led recovery projects typically run four to ten weeks. Time-sensitive lease-end cleanouts can be compressed; tell us your deadline up front and we will scope accordingly.

What types of lab equipment have resale value?+

Analytical instruments (HPLC, GC, LC/MS, GC/MS, spectrophotometers, plate readers), bioprocessing systems, ULT freezers and cold storage, centrifuges, incubators, microscopes, liquid handlers, and most automation platforms retain meaningful resale value. Generic glassware, consumables, and heavily customized one-off setups generally do not.

Can you help with a biotech company shutdown?+

Yes. Biotech shutdowns and wind-downs are one of the most common contexts pForm operates in. We coordinate with leadership, facilities, and counsel to recover value across the equipment footprint while keeping the closure timeline on track.

Do you handle pharmaceutical lab closures?+

Yes. Pharmaceutical lab closures — site consolidations, R&D footprint reductions, or full pharma facility shutdowns — are handled through the same process, with extra attention to documentation requirements and internal review of regulated equipment.

Do you provide lab equipment valuation before liquidation?+

We provide a market-recovery estimate based on the asset list, photos, condition, and current buyer demand. It is a commercial valuation for planning purposes, not a certified appraisal. If a formal appraisal is required for accounting, tax, or legal reasons, we can refer qualified appraisers.

What information should I prepare before contacting pForm?+

An asset list (spreadsheet is fine), photos of major instruments, manufacturer and model numbers, serial numbers when available, quantities, condition and test status, location, your closure timeline or hard deadline, and site access notes such as loading dock, elevator, or forklift availability.

Can you help with equipment that has not been tested?+

Yes. Untested equipment is common in fast closures and we factor it into the disposition strategy. Untested instruments typically realize less than tested ones, but bundled sales and auctions can still recover meaningful value when timeline doesn't allow for full functional testing.

Do you coordinate freight or pickup?+

Yes. pForm coordinates removal, freight, palletizing, and pickup scheduling with the facility, buyers, and transit providers. We work to align removals with your closure timeline, lease end, or building handback date.

Don't leave equipment value on the table

Before surplus lab equipment is abandoned, scrapped, or sold below market, pForm can help evaluate the best asset recovery path for your closure, relocation, or wind-down — and put a structured plan in place to execute it.